Patents Assigned to Arch Development
  • Patent number: 5343390
    Abstract: An automated method and system for discriminating between normal lungs and abnormal lungs having interstitial disease and/or septal lines, wherein a large number of adjacent regions of interest (ROIs) are selected, corresponding to an area on a digital image of a patient's lungs. The ROIs each contain a number of square or rectangular pixel arrays and are selected to sequentially fill in the total selected area of the lungs to be analyzed. A background trend is removed from each individual ROI and the ROIs are then analyzed to determine those exhibiting sharp edges, i.e., high edge gradients. A percentage of these sharp-edged ROIs are removed from the original sample based on the edge gradient analysis, a majority of which correspond to rib-edge containing ROIs. After removal of the sharp-edged ROIs, texture measurements are taken on the remaining sample in order to compare such data with predetermined data for normal and abnormal lungs.
    Type: Grant
    Filed: February 28, 1992
    Date of Patent: August 30, 1994
    Assignee: Arch Development Corporation
    Inventors: Kunio Doi, Xuan Chen, Shigehiko Katsuragawa
  • Patent number: 5341291
    Abstract: An interactive medical test selector for use by a patient is about the size of a book and has a screen for displaying questions to a patient, a limited number of keys by which the patient can enter answers, and a memory device for storing the patient's answers. The test selector is battery-powered for portability and uses a low-power liquid crystal display or the like to display instructions and medical questions to the patient. Only four keys are seen or used by the patient for answering the questions: YES, NO, NOT SURE, and NEXT QUESTION. Additional control keys used by the medical staff are hidden from the patient. The device is controlled by a pre-programmed microcomputer on a chip, and a ROM-based, removeable and replaceable control program which not only collects, but also analyzes the patient's answers and makes appropriate recommendations based on those answers, and drives a remote printer or computer terminal.
    Type: Grant
    Filed: March 8, 1993
    Date of Patent: August 23, 1994
    Assignee: Arch Development Corporation
    Inventors: Michael Roizen, William E. Turcotte, II, Richard E. Pfisterer
  • Patent number: 5336891
    Abstract: A system for reducing aberration effects in a charged particle beam. The system includes a source of charged particles, such as electrons or ions, and various building blocks for operating on the charged particle beam to generate a desired particle beam pattern. These building blocks can include at least one of a uniform magnetic field component and a uniform electrostatic field component arrangeable in different combinations, enabling coefficients of spherical and chromatic aberration to be canceled out thereby providing a charged particle beam having greatly diminished aberration.
    Type: Grant
    Filed: June 16, 1992
    Date of Patent: August 9, 1994
    Assignee: ARCH Development Corporation
    Inventor: Albert V. Crewe
  • Patent number: 5334498
    Abstract: The present invention provides the gene product of the herpes simplex virus U.sub.L 13 gene as being capable of phosphorylating other gene products of the herpes simplex virus. The herpes simplex virus U.sub.L 13 gene product is used in an assay to identify substances suspected of having anti-herpes simplex viral activity.
    Type: Grant
    Filed: August 18, 1992
    Date of Patent: August 2, 1994
    Assignee: Arch Development Corporation
    Inventors: Bernard Roizman, Frances C. Purves
  • Patent number: 5332531
    Abstract: Thermodynamically-unstable complexing agents which are diphosphonic acids and diphosphonic acid derivatives (or sulphur containing analogs), like carboxyhydroxymethanediphosphonic acid and vinylidene-1,1-diphosphonic acid, are capable of complexing with metal ions, and especially metal ions in the II, III, IV, V and VI oxidation states, to form stable, water-soluble metal ion complexes in moderately alkaline to highly-acidic media. However, the complexing agents can be decomposed, under mild conditions, into non-organic compounds which, for many purposes are environmentally-nondamaging compounds thereby degrading the complex and releasing the metal ion for disposal or recovery. Uses for such complexing agents as well as methods for their manufacture are also described.
    Type: Grant
    Filed: June 10, 1992
    Date of Patent: July 26, 1994
    Assignee: Arch Development Corporation
    Inventors: Earl P. Horwitz, Ralph C. Gatrone, Kenneth L. Nash
  • Patent number: 5328688
    Abstract: A virus is disclosed which is rendered avirulent by prevention of expression of an active product of a gene which is designated as .gamma..sub.1 34.5, which maps in the inverted repeats flanking the long unique sequence of herpes simplex virus DNA, and which is not essential for viral growth in cell culture. Viruses from which the gene was deleted or which carried stop codons are totally avirulent on intracerebral inoculation of mice.
    Type: Grant
    Filed: September 10, 1990
    Date of Patent: July 12, 1994
    Assignee: Arch Development Corporation
    Inventor: Bernard Roizman
  • Patent number: 5320800
    Abstract: A method for preparing a treated nanocrystalline metallic material. The method of preparation includes providing a starting nanocrystalline metallic material with a grain size less than about 35 nm, compacting the starting nanocrystalline metallic material in an inert atmosphere and annealing the compacted metallic material at a temperature less than about one-half the melting point of the metallic material.
    Type: Grant
    Filed: June 30, 1993
    Date of Patent: June 14, 1994
    Assignees: ARCH Development Corporation, Northwestern University
    Inventors: Richard W. Siegel, G. William Nieman, Julia R. Weertman
  • Patent number: 5319549
    Abstract: A computerized method and system based on quantitative analysis of geometric features of various infiltrate patterns in chest images for the detection and categorization of abnormalities related to the infiltrate patterns. Chest images are digitized and a lung texture analysis is performed on a number of small regions of interest (ROIs) in order to determine a classification of normal or abnormal of the particular patient's lungs. If the lungs are determined as being abnormal, large ROIs with a 128.times.128 matrix are selected in order to cover the detected areas of abnormality. Overall background trend correction is then performed in these large ROIs using a 2D-surface fitting technique for isolation of the fluctuating patterns of the underlying lung texture. Opacities of interstitial infiltrates are identified from two processed images which are obtained by employing thresholding with a morphological filter and a line enhancement filter.
    Type: Grant
    Filed: November 25, 1992
    Date of Patent: June 7, 1994
    Assignee: Arch Development Corporation
    Inventors: Shigehiko Katsuragawa, Kunio Doi
  • Patent number: 5308317
    Abstract: A protective tube for a laser endoscope that prevents the passage of laser smoke towards the oral cavity of a patient, removes debris from the endoscope and which is adapted to be inserted through the oral cavity and into an esophagus of a patient receiving medical treatment, the protective tube comprising a curved resilient member having a proximal end and a distal end, the proximal end including a mouthpiece and the distal end including a first sealing means and a second sealing means, the first sealing means forming a first seal between an outer surface of the tube and an inner surface of the esophagus and the second sealing means forming a second seal between an inner surface of the tube and an outer surface of the laser endoscope.
    Type: Grant
    Filed: June 7, 1990
    Date of Patent: May 3, 1994
    Assignee: Arch Development Corporation
    Inventors: Mark K. Ferguson, David Schucart, Lev Melinyshyn
  • Patent number: 5306683
    Abstract: A zeolite based catalyst for activation and conversion of methane. A zeolite support includes a transition metal (Mo, Cr or W) sulfide disposed within the micropores of the zeolite. The catalyst allows activation and conversion of methane to C.sub.2 + hydrocarbons in a reducing atmosphere, thereby avoiding formation of oxides of carbon.
    Type: Grant
    Filed: May 1, 1992
    Date of Patent: April 26, 1994
    Assignee: ARCH Development Corporation
    Inventors: Victor A. Maroni, Lennox E. Iton, James W. Pasterczyk, Markus Winterer, Theodore R. Krause
  • Patent number: 5289374
    Abstract: A computerized method and system for reducing the number of false-positive detections of nodule candidates in the detection of abnormalities in digital chest radiography. The image is initially subjected to an image difference technique where the detection sensitivity is increased so as to avoid missing small nodules which might otherwise go undetected. Such a technique tends to increase the number of false-positives, however, leading to possible incorrect diagnoses of the radiographs. To reduce the number of false-positives, feature extraction techniques are applied to grown regions around the nodule candidates, in order to provide computer generated information concerning the candidates. A data base of parameters common to false-positives is compared to calculated parameters of a candidate of interest. The candidates with grown region parameters within the data base range common to false-positives are eliminated as being probable false-positive detections due to normal background anatomical features.
    Type: Grant
    Filed: February 28, 1992
    Date of Patent: February 22, 1994
    Assignee: Arch Development Corporation
    Inventors: Kunio Doi, Tsuneo Matsumoto, Maryellen L. Giger, Akiko Kano
  • Patent number: 5288641
    Abstract: A foreign gene is inserted into a viral genome under the control of promoter-regulatory regions of the genome, thus providing a vector for the expression of the foreign gene. DNA constructs, plasmid vectors containing the constructs useful for expression of the foreign gene, recombinant viruses produced with the vector, and associated methods are disclosed.
    Type: Grant
    Filed: July 30, 1992
    Date of Patent: February 22, 1994
    Assignee: Arch Development Corporation
    Inventor: Bernard Roizman
  • Patent number: 5281631
    Abstract: An ion exchange resin for extracting metal ions from a liquid waste stream. An ion exchange resin is prepared by copolymerizing a vinylidene disphosphonic acid with styrene, acrylonitrile and divinylbenzene.
    Type: Grant
    Filed: December 20, 1991
    Date of Patent: January 25, 1994
    Assignee: Arch Development Corp.
    Inventors: E. Philip Horwitz, Spiro D. Alexandratos, Ralph C. Gatrone, Ronato Chiarizia
  • Patent number: 5264459
    Abstract: The present invention discloses improved methods for the treatment of autoimmune diseases using .beta.-adrenergic agonists, and particularly, .beta..sub.2 -adrenergic agonists. The treatment of animals with either EAE or EAN using the .beta..sub.2 -adrenergic agonist terbutaline significantly suppressed clinical disease. A Phase I safety treatment trial with terbutaline was conducted in MS patients. Twenty-four patients were treated for 4 weeks. No obvious side effects were observed. At 4 weeks, 15 of the 24 patients improved on neurologic rating scale and 17 patients reported subjective improvement. Treatment of rats with EAMG, an animal model of tThe government may own rights in the present invention pursuant to NIH grants 2 RO1 NS18413-07A1 and PO1NS-24575-03.
    Type: Grant
    Filed: July 13, 1992
    Date of Patent: November 23, 1993
    Assignee: ARCH Development Corporation
    Inventors: Ewa E. Chelmicka-Schorr, Barry G. W. Arnason, Anthony T. Reder, Louis Cohen
  • Patent number: 5254076
    Abstract: A method for mixing and separating immiscible liquid salts and liquid metals in a centrifugal contractor. The method includes introducing the liquids into an annular mixing zone and intensely mixing the liquids using vertical vanes attached to a rotor cooperating with vertical baffles, a horizontal baffle, and bottom vanes attached to the contactor housing. The liquids enter the contactor in the range of 700-800 degrees Celsius. The liquids are separated in the rotor into a dense phase and a light phase which are discharged from the contactor.
    Type: Grant
    Filed: August 6, 1992
    Date of Patent: October 19, 1993
    Assignee: ARCH Development Corporation
    Inventors: Lorac S. Chow, Ralph A. Leonard
  • Patent number: 5242873
    Abstract: An electrically conductive material for use in solid oxide fuel cells, electrochemical sensors for combustion exhaust, and various other applications possesses increased fracture toughness over available materials, while affording the same electrical conductivity. One embodiment of the sintered electrically conductive material consists essentially of cubic ZrO.sub.2 as a matrix and 6-19 wt. % monoclinic ZrO.sub.2 formed from particles having an average size equal to or greater than about 0.23 microns. Another embodiment of the electrically conductive material consists essentially at cubic ZrO.sub.2 as a matrix and 10-30 wt. % partially stabilized zirconia (PSZ) formed from particles having an average size of approximately 3 microns.
    Type: Grant
    Filed: April 18, 1988
    Date of Patent: September 7, 1993
    Assignee: ARCH Development Corporation
    Inventors: Jitendra P. Singh, Andrea L. Bosak, Charles C. McPheeters, Dennis W. Dees
  • Patent number: 5241578
    Abstract: An optical alignment system for aligning a film cassette carrying grid cassette with an x-ray source of a portable x-ray apparatus. To facilitate accurate alignment of the central x-ray beam of the x-ray source of a portable x-ray apparatus with a focused grid in a clinical setting, the present invention uses a light projector and a reflector device. The light projector is substantially fixed relative to the x-ray source and projects a spot or line of light on the surface of the grid cassette. The reflector device, which can be temporarily or permanently fixed to the grid cassette, includes a reflector surface and an image surface. Images of the incident light spot or line and of the reflected light spot or line are formed on the image surface, and the distance between the images indicates the magnitude of angulation alignment error between the grid cassette and the x-ray source.
    Type: Grant
    Filed: December 2, 1991
    Date of Patent: August 31, 1993
    Assignee: ARCH Development Corporation
    Inventor: Heber MacMahon
  • Patent number: 5229394
    Abstract: A method for treating ALS (Amyotrophic Lateral Sclerosis) is disclosed. The inventive method comprises the administration of controlled dosages of dextromethorphan in therapeutically effective amounts in a pharmaceutically acceptable vehicle Dextromethorphan (DMP) is a dimethylaminomethyl-substituted phenol, a sigma receptor antagonist known also as d-3-methoxy-N methylmorphinan, a d-isomer of the codeine analog, levorphanol. The inventive method has proven useful in controlling the progression of ALS in afflicted patients.
    Type: Grant
    Filed: July 30, 1990
    Date of Patent: July 20, 1993
    Assignee: Arch Development Corporation
    Inventor: Edgar F. Salazar-Grueso
  • Patent number: 5214981
    Abstract: A flywheel having superconductor bearings has a lower drag to lift ratio that translates to an improvement of a factor of ten in the rotational decay rate. The lower drag results from the lower dissipation of melt-processed YBCO, improved uniformity of the permanent magnet portion of the bearings, operation in a different range of vacuum pressure from that taught by the art, and greater separation distance from the rotating members of conductive materials.
    Type: Grant
    Filed: July 26, 1991
    Date of Patent: June 1, 1993
    Assignee: Arch Development Corporation
    Inventors: Bernard R. Weinberger, Lahmer Lynds, Jr., John R. Hull
  • Patent number: 5208263
    Abstract: Disclosed are novel classes of anti-androgen including dihydrophenanthrene derivatives, their method of synthesis and their use in treating disorders associated with excessive androgenic activities.
    Type: Grant
    Filed: September 27, 1989
    Date of Patent: May 4, 1993
    Assignee: Arch Development Corporation
    Inventors: Shutsung Liao, John Pataki, Ronald G. Harvey